GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » EBITDA Margin %

Xiangxue Pharmaceutical Co (SZSE:300147) EBITDA Margin % : -0.96% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Xiangxue Pharmaceutical Co's EBITDA for the three months ended in Sep. 2024 was ¥-4 Mil. Xiangxue Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was ¥437 Mil. Therefore, Xiangxue Pharmaceutical Co's EBITDA margin for the quarter that ended in Sep. 2024 was -0.96%.


Xiangxue Pharmaceutical Co EBITDA Margin % Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co EBITDA Margin % Chart

Xiangxue Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.73 10.40 -12.24 -2.71 3.71

Xiangxue Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.58 -35.58 4.46 -5.91 -0.96

Competitive Comparison of Xiangxue Pharmaceutical Co's EBITDA Margin %

For the Biotechnology subindustry, Xiangxue Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xiangxue Pharmaceutical Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiangxue Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Xiangxue Pharmaceutical Co's EBITDA Margin % falls into.



Xiangxue Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Xiangxue Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=85.406/2299.288
=3.71 %

Xiangxue Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-4.189/437.017
=-0.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xiangxue Pharmaceutical Co  (SZSE:300147) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Xiangxue Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiangxue Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663
Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.
Executives
Huang Wei Hua Supervisors
Tan Wen Hui Director
Kang Zhi Ying Executives
Ceng Lun Executives
Liu Yan Executives
Lu Feng Executives
Xu Li Secretary, Director
Mo Zi Yu Supervisors
Mai Zhen Jiang Supervisors
Wang Yong Hui Directors, executives
He Tao Executives
Fang Wei Min Supervisors
Huang Bin Directors, Directors, and Executives
Wu Jun Executives
Chen Wen Jin Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines